Noven Announces Appointment of Dr. Naruhito Higo as CEO

Noven Pharmaceutical has announced its decision to appoint Dr. Naruhito Higo as Chief Executive Officer effective O...

September 24, 2019 | Tuesday | News
Eisai, Meiji receive approval for Parkinson's drug

Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. have announced the manufacturing and marketing approval in Japan for th...

September 24, 2019 | Tuesday | News
Takeda receives Ministry approval for depression drug

Japanese firm Takeda Pharmaceutical Company Limited  and Denmark based H. Lundbeck A/S jointly announced that the M...

September 23, 2019 | Monday | News
Evrenzo gets approval in Japan to treat anemia associated with CKD

Astellas Pharma Inc. and FibroGen, Inc. have announced that Japan's Ministry of Health, Labour and Welfare (MH...

September 20, 2019 | Friday | News
Kao named to the Dow Jones Sustainability World Index

Kao Corporation has been selected for inclusion in the 2019 Dow Jones Sustainability World Index (DJSI World) and Dow Jo...

September 20, 2019 | Friday | News
Japan's Solasia set to start trials for Darinaparsin

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the targ...

September 20, 2019 | Friday | News
FDA approves combo drug to treat endometrial carcinoma

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...

September 19, 2019 | Thursday | News
Toyobo to market RNA analysis kit based on RIKEN technology

Japan headquartered Toyobo Co., Ltd. has productized a ribonucleic acid (RNA) analysis kit based on a novel system title...

September 19, 2019 | Thursday | News
Mitsubishi Tanabe, Daiichi Sankyo tie alliance for ALS treatment agent

Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Company Limited have announced that they have concluded a licens...

September 18, 2019 | Wednesday | News
Seattle Genetics, Astellas gets USFDA priority review for Enfortumab Vedotin

Seattle Genetics, Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has...

September 17, 2019 | Tuesday | News
Astellas, iota Biosciences enter into collaborative R&D agreement

Japanese firm Astellas Pharma and iota Biosciences, Inc. have announced a joint research and development agree...

September 17, 2019 | Tuesday | News
Eisai, Biogen discontinue clinical studies on AD drug candidate

Japan headquartered Eisai Co., Ltd. and US based Biogen Inc. have announced the decision to discontinue the Phase III cl...

September 16, 2019 | Monday | News
Astellas to accelerate early drug discovery

Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US ...

September 13, 2019 | Friday | News
Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...

September 12, 2019 | Thursday | News
Daiichi Sankyo brings new formulation for cancer pain treatment

Daiichi Sankyo Company Limited has announced it has launched a new generic formulation of oxycodone hydrochloride hydrat...

September 12, 2019 | Thursday | News
Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...

September 10, 2019 | Tuesday | News
Takeda issues US recall of NATPARA, a parathyroid hormone

Takeda Pharmaceutical Company Limited, on 6 Sep 2019, announced that the company is issuing a US recall for all doses of...

September 9, 2019 | Monday | News
Eisai launches antimicrobial wet wipes

Eisai Co., Ltd. has launched Etak® Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-...

September 9, 2019 | Monday | News